# Nulatis Therapeutics, Inc.: Form D filing

Nulatis Therapeutics, Inc., a pharmaceuticals company in Yardley, PA, filed a Form D with the SEC in 2009. The latest, on September 11, 2009, reports $557 sold of a $557 offering to 2 investors.

Find out what Nulatis Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Nulatis%20Therapeutics%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Nulatis%20Therapeutics%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fnulatis-therapeutics-inc-1472106)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Nulatis%20Therapeutics%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Nulatis%20Therapeutics%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fnulatis-therapeutics-inc-1472106)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Pennsylvania](https://specstream.ai/data/form-d/state/pennsylvania): 987 rows, by operating companies, filed since November 1, 2024, $49.35, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/pennsylvania
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 1020 STONY HILL ROAD, Yardley, PA, 19067
- Phone: (609) 730-7588
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2009
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1472106

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sep 11, 2009 | New notice | $557 | $557 | $0 | 2 | Sep 8, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1472106/000147210609000001/0001472106-09-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Janet Vergis | Executive Officer, Director, Promoter |  |

## Other pharmaceuticals companies in Pennsylvania that filed recently

- [Telemachus Therapeutics, Inc.](https://specstream.ai/data/form-d/company/telemachus-therapeutics-inc-2152986) $375,000 · Oct 28, 2026
- [EpiVario Inc.](https://specstream.ai/data/form-d/company/epivario-inc-1753351) $185,000 · Oct 13, 2026
- [Maxona Pharmaceuticals, Inc.](https://specstream.ai/data/form-d/company/maxona-pharmaceuticals-inc-1857448) $5.8 million · Aug 14, 2026

[Every Form D from the week of Sep 7, 2009](https://specstream.ai/data/form-d/week/2009-09-07) · [All recent filings in Pennsylvania](https://specstream.ai/data/form-d/state/pennsylvania) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Nulatis Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).